The high ambitions of Gatineau marijuana producer Hydropothecary (TSX-V:THCX) won’t stop at Quebec, says company co-founder and CEO Sébastien St-Louis.
“Hydropothecary is currently a leader in medical cannabis, both in Quebec and Canada,” says Mr. St-Louis.
“When (the federal government) legalizes marijuana for the adult-use recreational market, we intend to continue to be a leader and we’re targeting a 10 per cent market share in Canada, before launching internationally.”
(Sponsored)
How shared goals at Tamarack Ottawa Race Weekend strengthen workplace culture
Across workplaces of all sizes and sectors, organizations are continuing to look for meaningful ways to bring people together. Team connection, employee well-being, and community impact are no longer separate
The story behind Glenview Homes’ 2025 GOHBA award-winning Reveli floor plan
When Glenview Homes’ Design and Drafting Manager Eno Reveli sat down to design a new production floor plan, he wasn’t thinking about awards or show homes. He was thinking about
The company held a groundbreaking ceremony this week for a new 250,000-square-foot greenhouse. Politicians, employees, dignitaries and local residents were among those present. Once complete, the $25-million facility will bring Hydropothecary‘s growing capacity to 300,000 square feet and 25,000 kilograms annually of dried cannabis.
Hydropothecary says that an additional 100 full-time jobs will be created when the building is in full production. That’s on top of the existing 98 people, many from the local area, in positions ranging from operations to executive-level roles at the facility.
With marijuana legalization only months away, pot producers are racing to scale up production to both meet the demand of the adult recreational market and achieve economies of scale.
The latter point is especially important, given that the federal government has committed to keeping the price of pot relatively low in an effort to stamp out the black market.
